Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). WIN-Partners Co's share price for the quarter that ended in Mar. 2026 was 円1369. WIN-Partners Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 27 Mil. Therefore, WIN-Partners Co's market cap for the quarter that ended in Mar. 2026 was 円37,646 Mil.
WIN-Partners Co's quarterly market cap
declined
from Mar. 2025 (円37,882 Mil) to Sep. 2025 (円36,860 Mil) but then
increased
from Sep. 2025 (円36,860 Mil) to Mar. 2026 (円37,646 Mil).
WIN-Partners Co's annual market cap
increased
from Mar. 2024 (円34,874 Mil) to Mar. 2025 (円37,882 Mil) but then
declined
from Mar. 2025 (円37,882 Mil) to Mar. 2026 (円37,646 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. WIN-Partners Co's Enterprise Value for Today is 円20,117 Mil.
WIN-Partners Co (TSE:3183) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
WIN-Partners Co Market Cap Related Terms
WIN-Partners Co Market Cap Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, WIN-Partners Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Market Cap distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
WIN-Partners Co's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WIN-Partners Co (TSE:3183) has a Market Cap of 円35,336 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on WIN-Partners Co and its competitors. According to the industry distribution chart, WIN-Partners Co ranks #51 out of 120 companies in the Medical Distribution industry, placing it in the top 42.5%.
Is WIN-Partners Co's Market Cap too high?
WIN-Partners Co's current Market Cap is 円35,336 Mil. Based on the distribution chart, WIN-Partners Co ranks #51 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #51 out of 120 companies for Market Cap. This puts WIN-Partners Co in the upper half of its industry. The industry median Market Cap is 149.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 149.35, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median Market Cap is 149.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current Market Cap is 円35,336 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current Market Cap is 円35,336 Mil. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current Market Cap is 円35,336 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
Market Cap: 円35,336 Mil
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
